Company Registration No. 11841031 (England and Wales)
SAVILLE PHARMACY LTD
Unaudited accounts
for the year ended 29 February 2024
SAVILLE PHARMACY LTD
Unaudited accounts
Contents
SAVILLE PHARMACY LTD
Statement of financial position
as at 29 February 2024
Intangible assets
600,000
600,000
Tangible assets
72,000
3,000
Cash at bank and in hand
29,230
74,592
Creditors: amounts falling due within one year
(81,680)
(81,200)
Net current assets
34,794
111,154
Total assets less current liabilities
706,794
714,154
Creditors: amounts falling due after more than one year
(570,025)
(568,469)
Net assets
136,769
145,685
Called up share capital
1
1
Profit and loss account
136,768
145,684
Shareholders' funds
136,769
145,685
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 18 November 2024 and were signed on its behalf by
Lyakat Gulamhusein Jaffer
Director
Company Registration No. 11841031
SAVILLE PHARMACY LTD
Notes to the Accounts
for the year ended 29 February 2024
SAVILLE PHARMACY LTD is a private company, limited by shares, registered in England and Wales, registration number 11841031. The registered office is 111A HIGH STREET, WEALDSTONE, HARROW, MIDDLESEX, HA3 5DL.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
5 years straight line
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Total
At 29 February 2024
600,000
At 29 February 2024
600,000
At 28 February 2023
600,000
SAVILLE PHARMACY LTD
Notes to the Accounts
for the year ended 29 February 2024
5
Tangible fixed assets
Total
At 29 February 2024
95,000
Charge for the year
11,000
At 29 February 2024
23,000
At 29 February 2024
72,000
6
Average number of employees
During the year the average number of employees was 10 (2023: 7).